Zim Laboratories Ltd

ZIMLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹329 cr, stock is ranked 1,444
High RiskStock is 3.85x as volatile as Nifty
211.959.35 (+4.62%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹329 cr, stock is ranked 1,444
High RiskStock is 3.85x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
44.95
PB RatioPB Ratio
2.05
Dividend YieldDiv. Yield
Sector PESector PE
34.71
Sector PBSector PB
4.70
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Zim Laboratories, Ltd. is an India-based company, which manufactures pharmaceuticals in allopathic and herbal categories in India and internationally. The Company also offers pharmaceutical product development and manufacturing services.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021282.09337.42282.26309.6019.1215.353.297.32
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Board Meeting 
Announced OnMay 14, 2022

Zim Laboratories Ltd - 541400 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. | Download

Zim Laboratories Ltd - 541400 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. | Download

Cash Dividend 
Ex. DateSep 19, 2019

Final • Div/Share: ₹ 0.5

Cash Dividend 
Ex. DateSep 3, 2018

Final • Div/Share: ₹ 1

See all events